| 摘要 |
A method of reducing human immunodeficiency virus infective events by applying terygyn and a suitable excipient formulated for topical administration to the vaginal, anal, urethral or penile glans mucosa of an individual prior to or subsequent to infection by human immunodeficiency virus is herein described.
|
